Only a small percentage of older adults with early Alzheimer’s eligible for new treatments

Only a small percentage of older adults who are in the early stages of Alzheimer’s disease meet the eligibility criteria to receive new monoclonal antibody treatments, drugs that target amyloid-ß plaques in the brain, an early sign of Alzheimer’s disease.

Measuring blood plasma viscosity in COVID-19 using Brillouin light scattering spectroscopy

A research team led by MedUni Vienna has shown in a study that purely optical measurements of the viscosity of blood plasma may provide information

August 6, 2024

Parkinsonism in Athletes Linked With Chronic Traumatic Encephalopathy Pathology

Parkinsonism was linked with CTE in athletes, cross-sectional data suggested. Nearly 25% of deceased contact sports participants with CTE had parkinsonism symptoms before they died.

July 17, 2024

Viatris licenses Idorsia’s PhIII heart and lupus drugs with $350M upfront

Viatris has inked a deal with Idorsia for a pair of late-stage drug candidates in a move that may reflect Viatris’ efforts to build its

February 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.